ENHANCING DIAGNOSTIC ACCURACY IN POLYCYSTIC OVARY SYNDROME USING NOVEL INFLAMMATORY INDICES
Open Access
- 25 August 2025
- journal article
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 27 (2) , 217-224
Abstract
Objectives: Polycystic ovary syndrome (PCOS) is characterized by a complicated and incompletely understood pathophysiology. This study investigates the role of inflammation in its pathophysiology, compares the diagnostic performance of inflammatory indices, and assesses the clinical utility of novel biomarkers. Material and Methods: This retrospective study included 30 patients with PCOS and 32 healthy controls. Inflammatory indices including neutrophil to lymphocyte ratio (NLR), monocyte to lymphocyte ratio (MLR), neutrophil to monocyte ratio (NMR), platelet to lymphocyte ratio (PLR), platelet large cell ratio (PLCR), mean platelet volume to lymphocyte ratio (MPVLR), systemic immune inflammation index (SII), systemic inflammation response index (SIRI), multi-inflammatory index (MII), and monocyte to high density lipoprotein ratio (MHR) were calculated. Receiver operating characteristic (ROC) curve analysis evaluated their diagnostic performance. Biochemical, hormonal, hematological, and inflammatory parameters were measured using ELISA and an automated analyzer. Results: Inflammatory indices SII (p=0.006), SIRI (p=0.022), MII (p=0.013), and MHR (p=0.003) were significantly higher in patients, while PLCR was lower (p=0.024). Biochemical parameters CRP (p=0.027), insulin (p=0.021), and LDL (p=0.027) were elevated, HDL decreased (p=0.035). ROC analysis identified MHR as the most accurate biomarker (AUC=0.747, 100% specificity), followed by CRP (AUC=0.726) and MII (AUC=0.713). SII and SIRI showed moderate but relevant accuracy. All were statistically significant (p< 0.05). Conclusion: The present study highlights the potential of inflammation-based indices particularly MHR, MII, SII, SIRI, and CRP as valuable biomarkers in PCOS diagnosis. MHR showed the strongest diagnostic performance (100% specificity), while CRP and MII also demonstrated good accuracy. SIRI’s high sensitivity supports its role in early detection, and both SII and SIRI may serve as complementary markers. Overall, the results underscore the significance of inflammation in PCOS and support the clinical utility of these markers. PCOS influences hematological and biochemical parameters as well as inflammatory indices.Keywords
This publication has 33 references indexed in Scilit:
- Differentiating Kawasaki Disease and Multisystem Inflammatory Syndrome in Children Using Blood Composite Scores: Insights into Clinical Outcomes and Predictive IndicesPediatric Cardiology, 2025
- Multi-inflammatory index as a new predictive and prognostic marker of acute symptomatic seizures in patients with cerebral venous sinus thrombosisJournal of Stroke and Cerebrovascular Diseases, 2023
- Comparison of the different PCOS phenotypes based on monocyte to HDL cholesterol ratioJournal of Obstetrics and Gynaecology, 2022
- Higher dietary inflammation potential and certain dietary patterns are associated with polycystic ovary syndrome risk in China: A case-control studyNutrition Research, 2022
- Efficiency of Lymphocyte-to-Monocyte Ratio in Differential Diagnosis of Parapneumonic Effusion and Thoracic EmpyemaSurgical Infections, 2020
- The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndromeClínica e Investigación en Arteriosclerosis, 2020
- Can monocyte to HDL cholesterol ratio and monocyte to lymphocyte ratio be markers for inflammation and oxidative stress in patients with vitiligo? A preliminary studyArchives of Dermatological Research, 2020
- Immature Platelets As a Predictor of Disease Severity and Mortality in Sepsis and Septic Shock: A Systematic ReviewSeminars in Thrombosis and Hemostasis, 2019
- Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?Mediators of Inflammation, 2018
- A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapyCancer, 2016